483
Dendreon CorporationDendreon Corporation – FDA 483, Nov 2, 2018
Record Details
Dendreon Pharmaceuticals, LLC in Seattle, WA, was cited for significant deficiencies in their analytical testing laboratory during an FDA inspection. The firm failed to maintain consistency between their internal documents and the Biologics License Application, exhibited poor control over computer systems leading to data integrity concerns, and inadequately investigated out-of-specification results. Additionally, the inspection revealed a lack of proper training re-qualification for analysts.
View Company Profile
ID · c069757e-3fbd-4914-9602-d4ac0aa73138
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.